down arrow

Orchid Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE191A01027
  • NSEID: ORCHPHARMA
  • BSEID: 524372
INR
727.95
22.95 (3.26%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 43.35 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

718.10735.30

52 Week

670.051,998.00
Valuation
Technical
Day's Volume

CASH

43.35 k (-30.94%) Volume

Shareholding (Dec 2024)

FII

2.53%

Held by 66 FIIs

DII

18.99%

Held by 23 DIIs

Promoter

69.84%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 4.93%

  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.33
2

The company has declared negative results in Dec'2024 after 2 consecutive positive quarters

3

Stock is technically in a Bearish range

4

With ROE of 9.7, it has a Expensive valuation with a 2.9 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 3,692 Cr (Small Cap)

stock-summary
P/E

32.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.06

stock-summary
Return on Equity

9.72%

stock-summary
Price to Book

2.92

Revenue and Profits (1 Year):
Net Sales:
217 Cr
(Quarterly Results - Dec 2024)
Net Profit:
21 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-47.54%
0%
-47.54%
1 Year
-37.22%
0%
-37.22%
2 Years
86.2%
0%
86.2%
3 Years
81.53%
0%
81.53%
4 Years
-63.66%
0%
-63.66%
5 Years
13765.71%
0%
13765.71%

Latest dividend: 3 per share ex-dividend date: Sep-13-2012

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
19.51%
EBIT Growth (5y)
29.81%
EBIT to Interest (avg)
1.33
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.53
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
21.52%
ROCE (avg)
-1.52%
ROE (avg)
4.93%
Valuation key factors
Factor
Value
P/E Ratio
32
Industry P/E
33
Price to Book Value
2.92
EV to EBIT
41.62
EV to EBITDA
29.61
EV to Capital Employed
3.05
EV to Sales
3.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
8.07%
ROE (Latest)
9.72%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 15 Schemes (17.46%)

FIIs

Held by 66 FIIs (2.53%)

Promoter with highest holding

Dhanuka Laboratories Limited (69.84%)

Highest Public shareholder

Quant Mutual Fund - Quant Small Cap Fund (6.83%)

Individual Investors Holdings

6.42%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -2.41% vs -8.88% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -23.72% vs -7.19% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "217.34",
          "val2": "222.70",
          "chgp": "-2.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "26.36",
          "val2": "30.34",
          "chgp": "-13.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.80",
          "val2": "3.33",
          "chgp": "14.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "20.78",
          "val2": "27.24",
          "chgp": "-23.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.13%",
          "val2": "13.62%",
          "chgp": "-1.49%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 22.38% vs 28.84% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 93.74% vs 243.12% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "467.10",
          "val2": "381.68",
          "chgp": "22.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "62.83",
          "val2": "45.46",
          "chgp": "38.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.83",
          "val2": "9.35",
          "chgp": "-26.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "56.59",
          "val2": "29.21",
          "chgp": "93.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.45%",
          "val2": "11.91%",
          "chgp": "1.54%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 13.64% vs 32.08% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 31.94% vs 557.41% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "684.44",
          "val2": "602.27",
          "chgp": "13.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "89.19",
          "val2": "80.85",
          "chgp": "10.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10.63",
          "val2": "12.89",
          "chgp": "-17.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "77.37",
          "val2": "58.64",
          "chgp": "31.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.03%",
          "val2": "13.42%",
          "chgp": "-0.39%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 23.05% vs 19.00% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 98.99% vs 2,475.38% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "819.37",
          "val2": "665.90",
          "chgp": "23.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "110.68",
          "val2": "83.62",
          "chgp": "32.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "16.35",
          "val2": "32.23",
          "chgp": "-49.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-6.78",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "92.17",
          "val2": "46.32",
          "chgp": "98.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.51%",
          "val2": "12.56%",
          "chgp": "0.95%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
217.34
222.70
-2.41%
Operating Profit (PBDIT) excl Other Income
26.36
30.34
-13.12%
Interest
3.80
3.33
14.11%
Exceptional Items
0.00
0.00
Consolidate Net Profit
20.78
27.24
-23.72%
Operating Profit Margin (Excl OI)
12.13%
13.62%
-1.49%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -2.41% vs -8.88% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -23.72% vs -7.19% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
467.10
381.68
22.38%
Operating Profit (PBDIT) excl Other Income
62.83
45.46
38.21%
Interest
6.83
9.35
-26.95%
Exceptional Items
0.00
0.00
Consolidate Net Profit
56.59
29.21
93.74%
Operating Profit Margin (Excl OI)
13.45%
11.91%
1.54%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 22.38% vs 28.84% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 93.74% vs 243.12% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
684.44
602.27
13.64%
Operating Profit (PBDIT) excl Other Income
89.19
80.85
10.32%
Interest
10.63
12.89
-17.53%
Exceptional Items
0.00
0.00
Consolidate Net Profit
77.37
58.64
31.94%
Operating Profit Margin (Excl OI)
13.03%
13.42%
-0.39%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 13.64% vs 32.08% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 31.94% vs 557.41% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
819.37
665.90
23.05%
Operating Profit (PBDIT) excl Other Income
110.68
83.62
32.36%
Interest
16.35
32.23
-49.27%
Exceptional Items
0.00
-6.78
100.00%
Consolidate Net Profit
92.17
46.32
98.99%
Operating Profit Margin (Excl OI)
13.51%
12.56%
0.95%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 23.05% vs 19.00% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 98.99% vs 2,475.38% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Orchid Pharma Ltd stock-summary
stock-summary
Orchid Pharma Ltd
Small Cap
Pharmaceuticals & Drugs
Orchid Pharma Limited, is one of the leading pharmaceutical companies in India head quartered in Chennai and involved in development, manufacture and marketing of diverse bulk actives, formulations and nutraceuticals with exports spanning over 40 countries. Orchid's world class manufacturing infrastructure include USFDA compliant API and Finished Dosage Form facilities at Chennai in India.
Company Coordinates stock-summary
Company Details
Orchid Towers Nungambakkam, 313 Valluvar Kottam High Road Chennai Tamil Nadu : 600034
stock-summary
Tel: 91-44-28211000/28230000
stock-summary
http://www.orchidpharma.com
stock-summary
corporate@orchidpharma.com
Registrar Details
Integrated Enterprises (India) Ltd , II Floor , Kences Towers, No 1 Ramakrishna Street, North Usman Road, T Nagar, Chennai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."